EMBC

Embecta Corp

Oct 15 • 04:00PM ET

13.88

+0.35 2.59 %

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: DXCM PODD TNDM ABT MDT LCTX VTRS BAX BMY MRK

| Held by: IJR VTI IWM VB VXF IJS SPSM VBR IWN FNDA

Index	RUT	P/E	9.70	EPS (ttm)	1.43	Insider Own	7.14%	Shs Outstand	58.47M	Perf Week	0.43%
Market Cap	811.77M	Forward P/E	4.70	EPS next Y	2.95	Insider Trans	0.24%	Shs Float	54.31M	Perf Month	-7.96%
Enterprise Value	2.10B	PEG	1.36	EPS next Q	0.46	Inst Own	94.26%	Short Float	4.58%	Perf Quarter	40.91%
Income	83.60M	P/S	0.74	EPS this Y	19.39%	Inst Trans	-0.08%	Short Ratio	4.46	Perf Half Y	16.54%
Sales	1.10B	P/B	-	EPS next Y	0.94%	ROA	6.90%	Short Interest	2.49M	Perf YTD	-32.78%
Book/sh	-11.45	P/C	3.48	EPS next 5Y	7.14%	ROE	-	52W High	21.48 -35.38%	Perf Year	8.27%
Cash/sh	3.99	P/FCF	6.14	EPS past 3/5Y	-43.15% -	ROIC	10.08%	52W Low	9.20 50.87%	Perf 3Y	-51.09%
Dividend Est.	0.60 (4.31%)	EV/EBITDA	6.57	Sales past 3/5Y	-1.21% 0.25%	Gross Margin	61.88%	Volatility	3.61% 3.67%	Perf 5Y	-
Dividend TTM	0.60 (4.32%)	EV/Sales	1.90	EPS Y/Y TTM	18.55%	Oper. Margin	24.62%	ATR (14)	0.52	Perf 10Y	-
Dividend Ex-Date	Aug 29, 2025	Quick Ratio	1.78	Sales Y/Y TTM	-1.47%	Profit Margin	7.58%	RSI (14)	48.43	Recom	2.75
Dividend Gr. 3/5Y	- -	Current Ratio	2.47	EPS Q/Q	206.10%	SMA20	-1.48%	Beta	1.07	Target Price	16.67
Payout	44.70%	Debt/Eq	-	Sales Q/Q	8.44%	SMA50	-1.12%	Rel Volume	0.50	Prev Close	13.53
Employees	2100	LT Debt/Eq	-	Earnings	Aug 08 BMO	SMA200	3.51%	Avg Volume	557.18K	Price	13.88
IPO	Mar 22, 2022	Option/Short	Yes / Yes	EPS/Sales Surpr.	44.52% 6.20%	Trades		Volume	277,932	Change	2.59%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-10-25	Initiated	Mizuho	Neutral	$15
Dec-02-24	Upgrade	Morgan Stanley	Underweight → Equal-Weight	$13 → $20
Nov-27-24	Upgrade	BTIG Research	Neutral → Buy	$26
Oct-20-23	Initiated	Wolfe Research	Peer Perform
Jan-06-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$28
Sep-08-22	Initiated	BTIG Research	Neutral
Aug-01-22	Initiated	Morgan Stanley	Equal-Weight	$33
Jun-21-22	Initiated	BofA Securities	Underperform	$25

Oct-06-25 05:15AM	Best Value Stocks to Buy for October 6th (Zacks)
Sep-15-25 08:06AM	Best Income Stocks to Buy for September 15th (Zacks)
05:37AM	New Strong Buy Stocks for September 15th (Zacks)
Sep-09-25 04:12AM	Best Value Stocks to Buy for September 9th (Zacks)
Aug-26-25 05:00PM	embecta to Participate in Investor Events (GlobeNewswire)
09:30AM	Loading…
Aug-25-25 09:30AM	Embecta Corp. (EMBC) Crossed Above the 200-Day Moving Average: What That Means for Investors (Zacks)
Aug-12-25 09:55AM	Wall Street Analysts Predict a 25.69% Upside in Embecta Corp. (EMBC): Here's What You Should Know (Zacks)
Aug-09-25 03:03AM	Embecta Corp (EMBC) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Progress ... (GuruFocus.com)
Aug-08-25 06:30AM	Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results (GlobeNewswire) +18.53%
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Jul-24-25 05:00PM	embecta to Report Fiscal Third Quarter 2025 Financial Results (GlobeNewswire)
Jul-13-25 12:27AM	BTIG Lowers PT on Embecta Corp. (EMBC) to $25, Keeps a Buy Rating (Insider Monkey)
Jul-10-25 11:13AM	Mizuho Lowers PT on Embecta Corp. (EMBC) to $13 From $15, Keeps a Neutral Rating (Insider Monkey)
May-27-25 05:00PM	embecta to Participate in Investor Events (GlobeNewswire) +5.09% -6.31%
May-22-25 06:30AM	embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day (GlobeNewswire) -14.97%
10:50AM	Loading…
May-13-25 10:50AM	Embecta restructures again, outlines tariff costs (MedTech Dive)
May-10-25 05:16AM	Q2 2025 Embecta Corp Earnings Call (Thomson Reuters StreetEvents)
03:03AM	Embecta Corp (EMBC) Q2 2025 Earnings Call Highlights: Strategic Growth Amid Revenue Decline (GuruFocus.com)
May-09-25 12:10PM	Why Is Embecta Stock Falling On Friday? (Benzinga) -10.00%
07:40AM	Embecta Corp. (EMBC) Tops Q2 Earnings Estimates (Zacks)
06:30AM	Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
May-08-25 05:15PM	Solventum (SOLV) Tops Q1 Earnings and Revenue Estimates (Zacks) +6.66%
May-07-25 11:35AM	2024 Total Dividend Income And Portfolio Update (Seeking Alpha)
Apr-28-25 07:30AM	Embecta to host Analyst and Investor Day on May 22, 2025 (GlobeNewswire)
Apr-22-25 03:51AM	Beyond the drug: Closing the knowledge gap for injectable diabetes meds (Pharma Voice)
Apr-21-25 05:00PM	embecta to Report Fiscal Second Quarter 2025 Financial Results (GlobeNewswire)
Apr-01-25 08:05AM	Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations (GlobeNewswire)
Feb-19-25 03:36PM	Embecta Corp. (EMBC): Among Last Weeks Worst Dividend Stocks (Insider Monkey)
Feb-18-25 05:00PM	embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference (GlobeNewswire)
02:09AM	Loading…
Feb-07-25 02:09AM	Embecta Corp (EMBC) Q1 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic ... (GuruFocus.com)
Feb-06-25 07:45AM	Embecta Corp. (EMBC) Tops Q1 Earnings and Revenue Estimates (Zacks)
06:30AM	Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Jan-23-25 05:00PM	embecta to Report Fiscal First Quarter 2025 Financial Results (GlobeNewswire)
Dec-19-24 05:00PM	embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-09-24 08:50AM	Here Is Why Bargain Hunters Would Love Fast-paced Mover Embecta Corp. (EMBC) (Zacks)
Dec-06-24 06:00AM	Embecta to cut 125 jobs after ending insulin patch pump (MedTech Dive)
Nov-27-24 06:40AM	Embecta to discontinue insulin patch pump program, initiates restructuring plan (TipRanks) +10.11%
02:02AM	Embecta Corp (EMBC) Q4 2024 Earnings Call Highlights: Strategic Shifts and Financial Performance (GuruFocus.com)
12:26AM	Q4 2024 Embecta Corp Earnings Call (Thomson Reuters StreetEvents)
Nov-26-24 01:15PM	Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps (Benzinga) +29.77%
07:40AM	Embecta Corp. (EMBC) Tops Q4 Earnings and Revenue Estimates (Zacks)
06:40AM	Embecta discontinues insulin patch pump development (MedTech Dive)
06:30AM	Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Nov-18-24 10:00AM	Inside a $400 billion bet on the brain-computer interface revolution (Yahoo Finance)
Nov-12-24 05:31PM	UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
05:00PM	embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Nov-07-24 06:30AM	embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell (GlobeNewswire) -6.37%
Sep-03-24 07:55AM	Embecta gets FDA nod for insulin patch pump (MedTech Dive)
06:30AM	embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes (GlobeNewswire)
Aug-22-24 05:00PM	embecta to Participate in Investor Events (GlobeNewswire) +6.14%
Aug-12-24 09:35AM	Embecta Corp. (EMBC) Recently Broke Out Above the 20-Day Moving Average (Zacks)
09:30AM	Embecta Corp. (EMBC) Just Overtook the 200-Day Moving Average (Zacks)
Aug-10-24 08:18AM	Embecta Corp. (NASDAQ:EMBC) Q3 2024 Earnings Call Transcript (Insider Monkey)
Aug-09-24 10:52AM	EMBC Stock Earnings: Embecta Beats EPS, Beats Revenue for Q3 2024 (InvestorPlace) +7.32%
07:40AM	Embecta Corp. (EMBC) Tops Q3 Earnings and Revenue Estimates (Zacks)
06:30AM	Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Aug-02-24 10:00AM	Earnings Preview: Embecta Corp. (EMBC) Q3 Earnings Expected to Decline (Zacks)
Jul-31-24 09:47AM	Is the Options Market Predicting a Spike in Embecta Corp. (EMBC) Stock? (Zacks)
Jul-29-24 08:05AM	Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company (PR Newswire)
Jul-24-24 04:21AM	Strength Seen in Embecta Corp. (EMBC): Can Its 6.9% Jump Turn into More Strength? (Zacks)
Jul-22-24 07:42AM	Diabetes device firm Embecta considers sale: Financial Times (MedTech Dive) +15.26%
Jul-18-24 05:00PM	embecta to Report Fiscal Third Quarter 2024 Financial Results (GlobeNewswire)
Jun-25-24 07:47AM	Embecta touts its insulin patch pump at ADA (MedTech Dive)
Jun-24-24 06:30AM	embecta-sponsored Abstracts Presented at American Diabetes Association's 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir (GlobeNewswire)
Jun-20-24 07:30AM	Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors (PR Newswire)
May-21-24 04:30PM	Trade Winds Turning: 3 Stocks Poised to Gain from Biden's China Tariffs (InvestorPlace)
May-13-24 11:52AM	Embecta Corp. (NASDAQ:EMBC) Q2 2024 Earnings Call Transcript (Insider Monkey)
May-10-24 02:12PM	Embecta Corp (EMBC) Surpasses Analyst Revenue Forecasts in Q2 Fiscal 2024 (GuruFocus.com)
May-09-24 10:54AM	EMBC Stock Earnings: Embecta Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace) +37.88%
06:30AM	Embecta Corp. Reports Second Quarter Fiscal 2024 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
May-01-24 05:00PM	embecta to Participate in Investor Events (GlobeNewswire)
Apr-23-24 05:00PM	embecta to Report Fiscal Second Quarter 2024 Financial Results (GlobeNewswire)
Mar-06-24 06:00AM	embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes (GlobeNewswire)
Feb-10-24 08:55AM	Embecta Corp. (NASDAQ:EMBC) Q1 2024 Earnings Call Transcript (Insider Monkey)
Feb-09-24 10:07PM	Q1 2024 Embecta Corp Earnings Call (Thomson Reuters StreetEvents) -8.47% -7.91%
11:43AM	Why Embecta Stock Is Tanking Today (Motley Fool)
07:45AM	Embecta Corp. (EMBC) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
07:07AM	Embecta Corp (EMBC) Reports Modest Revenue Growth and Decline in Profitability in Q1 Fiscal 2024 (GuruFocus.com)
06:30AM	Embecta Corp. Reports First Quarter Fiscal 2024 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Feb-07-24 05:00PM	embecta to Participate in the 11th Annual BTIG MedTech Conference (GlobeNewswire)
Jan-24-24 05:00PM	embecta to Report Fiscal First Quarter 2024 Financial Results (GlobeNewswire)
Jan-21-24 08:33AM	16 Most Profitable New Stocks Today (Insider Monkey)
Jan-09-24 06:00AM	embecta Announces FDA 510(k) Submission for Insulin Patch Pump (GlobeNewswire)
Dec-14-23 05:00PM	embecta to Participate at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-01-23 06:00AM	No embecta-made syringes impacted by FDA safety communication (GlobeNewswire)
05:13AM	Embecta Corp's Dividend Analysis (GuruFocus.com)
Nov-29-23 05:00PM	embecta to Participate in Investor Conferences (GlobeNewswire)
Nov-22-23 09:34AM	Embecta Corp. (NASDAQ:EMBC) Q4 2023 Earnings Call Transcript (Insider Monkey)
Nov-21-23 07:23AM	Embecta CEO Dev Kurdikar talks about growth expectations, GLP-1s (MedTech Dive)
07:15AM	Embecta Corp. (EMBC) Beats Q4 Earnings and Revenue Estimates (Zacks)
07:13AM	Embecta Corp (EMBC) Posts Mixed Fiscal 2023 Results and Issues Fiscal 2024 Guidance (GuruFocus.com)
05:30AM	Embecta Corp. Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results and Provides Initial Fiscal 2024 Financial Guidance (GlobeNewswire)
05:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Nov-14-23 10:00AM	Earnings Preview: Embecta Corp. (EMBC) Q4 Earnings Expected to Decline (Zacks) +7.29%

Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Melcher David F	Director	May 23 '25	Buy	10.60	10,000	105,995	86,681	May 23 04:35 PM
Melcher David F	Director	Feb 25 '25	Buy	13.67	13,000	177,646	76,681	Feb 25 04:26 PM
Morris Milton Mayo	Director	Feb 13 '25	Sale	16.38	3,100	50,783	36,133	Feb 14 06:42 PM
Morris Milton Mayo	Director	Feb 13 '25	Proposed Sale	16.38	3,100	50,778		Feb 13 03:57 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EMBC

Embecta Corp

Upgrade your FINVIZ experience